News

404

PRISM BioLab and InveniAI Reached the First Milestone

PRISM BioLab and InveniAI Reached the First Milestone

PRISM BioLab and InveniAI Announce Successful Completion of Milestone in their Collaboration Focused on Designing Novel Inflammasome-Targeted Therapeutic Candidates

Read Full Press Release

Scroll to top
en_USEnglish